CEPI to support development of selfamplifying mRNA vaccine technology for use against Disease X
CEPI will provide up to $3.6 million to support the optimisation of the saRNA-platform technology, the production process, and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Coalition for Epidemic Preparedness Innovations
CEPI to help advance development and manufacture of COVID-19 vaccine from Biological E
CEPI will initially contribute up to $5 million toward the cost of scaling up the process for manufacturing the vaccine, and will…
Novavax commences Phase 2 clinical trial of COVID-19 vaccine candidate
Trial to enroll up to 1,500 volunteers in the US and Australia, with approximately 50 per cent between 60 and 84 years of age
Novavax announces collaboration with SK bioscience for COVID-19 vaccine
SK bioscience will manufacture the vaccine antigen component for use in the final drug product globally during the pandemic period